The UK is about to have its first space launch – but Cornwall is unlikely to become a new Cape Canaveral
Silicon is used in construction, microchips and more – 'green' methods could help extract it from sugarcane waste
Genetically engineered bacteria make living materials for self-repairing walls and cleaning up pollution
The resulting thermoplastic resin could be purified through a distillation process to make food-grade potassium lactate.
The ATV safety standards are meant to reduce crash and injury hazards that would prevent serious injury or death.
S. Korea’s Celltrion Partners with US firm Abpro for breast cancer treatment
South Korea’s Celltrion Inc. will jointly develop and work on the market release with Abpro Corp. of the US on a breast cancer treatment candidate ABP 10
Under the deal, Celltrion will receive US$10 million in milestone payments after successfully passing key stages of the development and approval cycle.
Celltrion, an Incheon-based biopharmaceutical company, will also be eligible to collect $1.75 billion from Abpro after ABP 102 generates sales following its market debut. Additionally, it has secured the rights for the candidate's international sales.
The Massachusetts-based Abpro is developing eight other cancer treatment candidates.
ABP 102 is a dual antibody treatment used to treat breast cancer that is HER2-positive.